Literature DB >> 26149537

Interactions between the intestinal microbiota and bile acids in gallstones patients.

Nirit Keren1,2, Fred M Konikoff1,2, Yossi Paitan3, Gila Gabay1, Leah Reshef4, Timna Naftali1,2, Uri Gophna4.   

Abstract

Cholecystectomy, surgical removal of the gallbladder, changes bile flow to the intestine and can therefore alter the bidirectional interactions between bile acids (BAs) and the intestinal microbiota. We quantified and correlated BAs and bacterial community composition in gallstone patients scheduled for cholecystectomy before and after the procedure, using gas-liquid chromatography and 16S rRNA amplicon sequencing, followed by quantitative real-time polymerase chain reaction of the phylum Bacteroidetes. Gallstone patients had higher overall concentrations of faecal BAs and a decreased microbial diversity, accompanied by a reduction in the beneficial genus Roseburia and an enrichment of the uncultivated genus Oscillospira, compared with controls. These two genera may thus serve as biomarkers for symptomatic gallstone formation. Oscillospira was correlated positively with secondary BAs and negatively with primary BAs, while the phylum Bacteroidetes showed an opposite trend. Cholecystectomy resulted in no substantial change in patients' faecal BAs. However, bacterial composition was significantly altered, with a significant increase in the phylum Bacteroidetes. Given that cholecystectomy has been associated with a higher risk of colorectal cancer and that members of the Bacteroidetes are increased in that disease, microbial consequences of cholecystectomy should be further explored.
© 2015 Society for Applied Microbiology and John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26149537     DOI: 10.1111/1758-2229.12319

Source DB:  PubMed          Journal:  Environ Microbiol Rep        ISSN: 1758-2229            Impact factor:   3.541


  49 in total

Review 1.  Cholecystectomy and risk of metabolic syndrome.

Authors:  Agostino Di Ciaula; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Eur J Intern Med       Date:  2018-04-26       Impact factor: 4.487

Review 2.  An update on the pathogenesis of cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q-H Wang; Piero Portincasa
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

3.  Cholecystectomy: a way forward and back to metabolic syndrome?

Authors:  Gabriella Garruti; David Q-H Wang; Agostino Di Ciaula; Piero Portincasa
Journal:  Lab Invest       Date:  2018-01       Impact factor: 5.662

Review 4.  The microbiome and lung cancer.

Authors:  Abhiram Maddi; Amarpreet Sabharwal; Timothy Violante; Sunita Manuballa; Robert Genco; Santosh Patnaik; Sai Yendamuri
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

Review 5.  Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention.

Authors:  Mingyang Song; Andrew T Chan
Journal:  Clin Gastroenterol Hepatol       Date:  2018-07-18       Impact factor: 11.382

6.  Gastrointestinal defects in gallstone and cholecystectomized patients.

Authors:  Agostino Di Ciaula; Emilio Molina-Molina; Leonilde Bonfrate; David Q-H Wang; Dan L Dumitrascu; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2019-01-29       Impact factor: 4.686

7.  Cholecystectomy and Biliary Sphincterotomy Increase Fecal Bile Loss and Improve Lipid Profile in Dyslipidemia.

Authors:  Ilia Sergeev; Nirit Keren; Timna Naftali; Fred M Konikoff
Journal:  Dig Dis Sci       Date:  2019-09-14       Impact factor: 3.199

8.  L-Glutamine Supplementation Alleviates Constipation during Late Gestation of Mini Sows by Modifying the Microbiota Composition in Feces.

Authors:  Yuanyuan Zhang; Taofeng Lu; Lingxia Han; Lili Zhao; Yinjie Niu; Hongyan Chen
Journal:  Biomed Res Int       Date:  2017-03-12       Impact factor: 3.411

Review 9.  Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation.

Authors:  Li Qi; Wanlin Dai; Jing Kong; Yu Tian; Yongsheng Chen
Journal:  J Physiol Biochem       Date:  2021-07-24       Impact factor: 4.158

10.  The relation between gallstone disease and cardiovascular disease.

Authors:  Lai Lai Fan; Bai Hui Chen; Zhi Juan Dai
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.